Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. (SBRT/IL-2)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Providence Health & Services
Sponsor:
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Providence Health & Services
ClinicalTrials.gov Identifier:
NCT01416831
First received: August 12, 2011
Last updated: October 14, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)